Kenvue Inc. Tylenol model ache reliever on the market at a pharmacy in New York, US, on Wednesday, March 27, 2024.
Bloomberg | Bloomberg | Getty Images
Shares of Kenvue fell greater than 10% on Friday after a report that Health and Human Services Secretary Robert F. Kennedy Jr. will probably hyperlink autism to the usage of the corporate’s ache treatment Tylenol in pregnant girls.
HHS will launch the report that might draw that hyperlink this month, the Wall Street Journal reported on Friday.
That report may also recommend a drugs derived from folate – a water-soluble vitamin – can be utilized to deal with signs of the developmental dysfunction in some individuals, in accordance with the Journal.
Tylenol may very well be the newest extensively used and accepted therapy that Kennedy has undermined on the helm of HHS, which oversees federal well being companies that regulate medication and different therapies. Kennedy has additionally taken steps to alter vaccine coverage within the U.S., and has amplified false claims about secure and efficient photographs that use mRNA expertise.
Kennedy has made the dysfunction a key focus of HHS, pledging in April that the company will “know what has caused the autism epidemic” by September and eradicate exposures. He also said that month that the company has launched a “massive testing and research effort” involving a whole lot of scientists worldwide that may decide the trigger.
In an announcement, Kenvue stated it has “continuously evaluated the science and [continues] to believe there is no causal link” between the usage of acetaminophen, the generic title for Tylenol, throughout being pregnant and autism.
The firm added that the Food and Drug Administration and main medical organizations “agree on the safety” of the drug, its use throughout being pregnant and the knowledge offered on the Tylenol label.
The FDA website says the company has not discovered “clear evidence” that applicable use of acetaminophen throughout being pregnant causes “adverse pregnancy, birth, neurobehavioral, or developmental outcomes.” But the FDA stated it advises pregnant girls to talk with their health-care suppliers earlier than utilizing over-the-counter medication.
This is breaking information. Please refresh for updates.